IL6 and type 2 diabetes mellitus: Moreover, although meta-analytic findings indicate improvements in inflammatory markers such as CRP, IL-6, TNF-α, and MDA, there remain inconsistencies across individual studies, particularly regarding the magnitude and durability of these effects, as well as their relevance to long-term T2DM outcomes.